(Total Views: 691)
Posted On: 07/26/2022 3:52:08 PM
Post# of 145247
I don't view it as speculation so much as potential. I bought CYDY for HIV in Sep 2019 at .39 and before all the Covid speculation there was the HIV potential which had us at 2.20-2.69 on Mar 1, 2020.
So is our potential any worse or better now? The Covid trials increase our awareness of the pathology behind Leronlimab and I would say increased our potential. So where, historically, should this share price be?
So is our potential any worse or better now? The Covid trials increase our awareness of the pathology behind Leronlimab and I would say increased our potential. So where, historically, should this share price be?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)